Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Meloxicam on Aspirin Antiplatelet Activity
NCT02187562Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2002
- Primary completion
- Aug 2002
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of meloxicam in osteoarthritis (OA) and rheumatoid arthritis (RA) (2 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Arachidonic acid induced platelet aggregation. Started Jul 2002; status: completed.
02
Drugs
meloxicam
03
Conditions
osteoarthritis (OA)rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02187562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02187562.